Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse-Reference-Cited by-同舟云学术

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse

Published:1998-09 Issue:2-3 Volume:357 Page:221-225
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Beales Philip E.,Liddi Roberto,Giorgini Angela E.,Signore Alberto,Procaccini Enrica,Batchelor Kenneth,Pozzilli Paolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference27 articles.

1. Insulin-dependent diabetes in the NOD mouse model: II. Beta-cell destruction in autoimmune diabetes is a Th1 and not a Th2 mediated event;Anderson;Autoimmunity,1993

2. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease;Bowman;Immunol. Today,1994

3. Troglitazone alters the cytokine production of activated lymphocytes from human donors;Giorgini;Diabetologia,1997

4. Isolation of the human peroxisome proliferator activated receptor-gamma cDNA: expression in hematopoietic cells and chromosomal mapping;Greene;Gene Expr.,1995

5. HMSO (Her Majesty's Stationary Office), London, 1986. Animals (Scientific Procedures) Act.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenolic Compounds Inhibit 3T3-L1 Adipogenesis Depending on the Stage of Differentiation and Their Binding Affinity to PPARγ;Molecules;2019-03-16

2. Insulin sensitizer prevents and ameliorates experimental type 1 diabetes;American Journal of Physiology-Endocrinology and Metabolism;2017-12-01

3. Metabolic Regulation of T Cell Immunity;Advances in Experimental Medicine and Biology;2017

4. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice;Journal of Biological Chemistry;2016-10

5. Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients;Clinical and Experimental Immunology;2013-01-03